| Trial Identifier: | D5160C00042 |
| Sponsor: | AstraZeneca |
| Collaborator: | Tigermed |
| NCTID: | NCT02997501 |
| Start Date: | December 2016 |
| Primary Completion Date: | October 2018 |
| Study Completion Date: | October 2018 |
| Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Chinese (Simplified) Translation | |
| English Version |
| Country | Location |
|---|---|
| China | Beijing, China, 100142 |
| China | Changchun, China, 130012 |
| China | Chengdu, China, 610041 |
| China | Chengdu, China, 610041 |
| China | Guangzhou, China, 510080 |
| China | Wuhan, China, 430030 |
| China | Wuhan, China, 430022 |
| China | Wuhan, China, 430079 |
| China | xi'an, China, 710038 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company